FDA Approved: NYMALIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

This FDA entry documents a supplemental application for NYMALIZE (nimodipine) by Azurity Pharmaceuticals, Inc., likely pertaining to labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• NYMALIZE (Nimodipine)

Snippet

SUPPL AP for NYMALIZE (NIMODIPINE)